PPS Treatment and COPPS Trial — EECC MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Post-pericardiotomy syndrome (PPS) — an inflammatory pericarditis occurring 2-6 weeks after cardiac surgery; treated with aspirin/NSAIDs plus colchicine, analogous to acute pericarditis
Post-pericardiotomy syndrome (PPS) is a form of pericarditis occurring in 10-40% of patients 2-6 weeks after cardiac surgery. It is an immune-mediated inflammatory response to pericardial injury and blood in the pericardial space. Diagnosis requires: fever, pleuritic chest pain, pericardial friction rub, new/worsening pericardial effusion, elevated inflammatory markers (CRP, ESR, WCC), and exclusion of other causes (wound infection, endocarditis, PE). Treatment: (1) aspirin or NSAIDs (preferred over ibuprofen post-cardiac surgery due to aspirin's antiplatelet effect in patients with prosthetic valves/grafts); (2) colchicine for 3 months (COPPS and COPPS-2 trials demonstrated that colchicine reduces PPS incidence when started perioperatively and treats established PPS). Corticosteroids are second-line due to recurrence risk.
Reference: ESC (2025): Myocarditis/Pericarditis Guidelines; COPPS Trial